Published in Front Neurosci on March 15, 2017
Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature (2002) 10.81
Amyloid deposits and amyloidosis. The beta-fibrilloses (first of two parts). N Engl J Med (1980) 9.38
Protein misfolding, evolution and disease. Trends Biochem Sci (1999) 7.73
Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease. Nat Med (2008) 6.86
Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci U S A (1993) 4.86
A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N Engl J Med (2001) 4.68
Structure of prealbumin: secondary, tertiary and quaternary interactions determined by Fourier refinement at 1.8 A. J Mol Biol (1978) 4.47
Functional amyloid formation within mammalian tissue. PLoS Biol (2006) 3.92
Functional amyloids as natural storage of peptide hormones in pituitary secretory granules. Science (2009) 3.78
Identifying the amylome, proteins capable of forming amyloid-like fibrils. Proc Natl Acad Sci U S A (2010) 3.50
Expression of human beta-amyloid peptide in transgenic Caenorhabditis elegans. Proc Natl Acad Sci U S A (1995) 3.36
Hydrophobic surfactant proteins in lung function and disease. N Engl J Med (2002) 2.94
Cellular processing of beta-amyloid precursor protein and the genesis of amyloid beta-peptide. Cell (1993) 2.89
The cerebrospinal-fluid soluble form of Alzheimer's amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex. Biochem J (1993) 2.66
Beta-amyloid precursor protein cleavage by a membrane-bound protease. Proc Natl Acad Sci U S A (1992) 2.55
A molecular chaperone breaks the catalytic cycle that generates toxic Aβ oligomers. Nat Struct Mol Biol (2015) 2.53
A stop-codon mutation in the BRI gene associated with familial British dementia. Nature (1999) 2.46
Transcriptional control of the mouse prealbumin (transthyretin) gene: both promoter sequences and a distinct enhancer are cell specific. Mol Cell Biol (1986) 2.43
The amyloid hypothesis of Alzheimer's disease at 25 years. EMBO Mol Med (2016) 2.31
Tissue damage in the amyloidoses: Transthyretin monomers and nonnative oligomers are the major cytotoxic species in tissue culture. Proc Natl Acad Sci U S A (2004) 2.14
Prediction of amyloid fibril-forming proteins. J Biol Chem (2000) 2.12
A decamer duplication in the 3' region of the BRI gene originates an amyloid peptide that is associated with dementia in a Danish kindred. Proc Natl Acad Sci U S A (2000) 2.11
Transthyretin aggregation under partially denaturing conditions is a downhill polymerization. Biochemistry (2004) 2.08
Transthyretin sequesters amyloid beta protein and prevents amyloid formation. Proc Natl Acad Sci U S A (1994) 1.94
Life on the edge: a link between gene expression levels and aggregation rates of human proteins. Trends Biochem Sci (2007) 1.88
Diversity, biogenesis and function of microbial amyloids. Trends Microbiol (2011) 1.86
An engineered transthyretin monomer that is nonamyloidogenic, unless it is partially denatured. Biochemistry (2001) 1.85
Mutations in the surfactant protein C gene associated with interstitial lung disease. Chest (2002) 1.74
The transthyretin amyloidoses: from delineating the molecular mechanism of aggregation linked to pathology to a regulatory-agency-approved drug. J Mol Biol (2012) 1.70
The familial dementia BRI2 gene binds the Alzheimer gene amyloid-beta precursor protein and inhibits amyloid-beta production. J Biol Chem (2005) 1.67
BRICHOS: a conserved domain in proteins associated with dementia, respiratory distress and cancer. Trends Biochem Sci (2002) 1.66
Surfactant protein C biosynthesis and its emerging role in conformational lung disease. Annu Rev Physiol (2005) 1.65
Transthyretin protects Alzheimer's mice from the behavioral and biochemical effects of Abeta toxicity. Proc Natl Acad Sci U S A (2008) 1.64
Furin mediates enhanced production of fibrillogenic ABri peptides in familial British dementia. Nat Neurosci (1999) 1.53
ApoE influences amyloid-β (Aβ) clearance despite minimal apoE/Aβ association in physiological conditions. Proc Natl Acad Sci U S A (2013) 1.50
BRI2 interacts with amyloid precursor protein (APP) and regulates amyloid beta (Abeta) production. J Biol Chem (2005) 1.48
The NMR structure of the pulmonary surfactant-associated polypeptide SP-C in an apolar solvent contains a valyl-rich alpha-helix. Biochemistry (1994) 1.47
Regulated intramembrane proteolysis of Bri2 (Itm2b) by ADAM10 and SPPL2a/SPPL2b. J Biol Chem (2007) 1.46
BRI2 inhibits amyloid beta-peptide precursor protein processing by interfering with the docking of secretases to the substrate. J Neurosci (2008) 1.42
Structure of the chromosomal gene for human serum prealbumin. Gene (1985) 1.40
A comparative analysis of 23 structures of the amyloidogenic protein transthyretin. J Mol Biol (2000) 1.34
Accelerated Abeta deposition in APPswe/PS1deltaE9 mice with hemizygous deletions of TTR (transthyretin). J Neurosci (2007) 1.29
Online registry for mutations in hereditary amyloidosis including nomenclature recommendations. Hum Mutat (2014) 1.23
Amyloidogenic potential of foie gras. Proc Natl Acad Sci U S A (2007) 1.21
Amyloid deposits in transthyretin-derived amyloidosis: cleaved transthyretin is associated with distinct amyloid morphology. J Pathol (2005) 1.21
Seeded strain-like transmission of β-amyloid morphotypes in APP transgenic mice. EMBO Rep (2013) 1.20
β- but not γ-secretase proteolysis of APP causes synaptic and memory deficits in a mouse model of dementia. EMBO Mol Med (2012) 1.20
Maturation of BRI2 generates a specific inhibitor that reduces APP processing at the plasma membrane and in endocytic vesicles. Neurobiol Aging (2009) 1.19
Familial Danish dementia: co-existence of Danish and Alzheimer amyloid subunits (ADan AND A{beta}) in the absence of compact plaques. J Biol Chem (2005) 1.18
Memory deficits due to familial British dementia BRI2 mutation are caused by loss of BRI2 function rather than amyloidosis. J Neurosci (2010) 1.14
Danish dementia mice suggest that loss of function and not the amyloid cascade causes synaptic plasticity and memory deficits. Proc Natl Acad Sci U S A (2010) 1.13
Neuronal production of transthyretin in human and murine Alzheimer's disease: is it protective? J Neurosci (2011) 1.13
Expression of BRI, the normal precursor of the amyloid protein of familial British dementia, in human brain. Acta Neuropathol (2003) 1.10
Surfactant protein C: its unique properties and emerging immunomodulatory role in the lung. Microbes Infect (2006) 1.09
Transthyretin binding to A-Beta peptide--impact on A-Beta fibrillogenesis and toxicity. FEBS Lett (2008) 1.09
Localization, synthesis, and processing of surfactant protein SP-C in rat lung analyzed by epitope-specific antipeptide antibodies. J Biol Chem (1994) 1.09
Neurotoxicity and memory deficits induced by soluble low-molecular-weight amyloid-β1-42 oligomers are revealed in vivo by using a novel animal model. J Neurosci (2012) 1.06
Support for the multigenic hypothesis of amyloidosis: the binding stoichiometry of retinol-binding protein, vitamin A, and thyroid hormone influences transthyretin amyloidogenicity in vitro. Proc Natl Acad Sci U S A (2001) 1.06
Mutations linked to interstitial lung disease can abrogate anti-amyloid function of prosurfactant protein C. Biochem J (2008) 1.06
High-resolution structure of a BRICHOS domain and its implications for anti-amyloid chaperone activity on lung surfactant protein C. Proc Natl Acad Sci U S A (2012) 1.06
Koch's postulates and infectious proteins. Acta Neuropathol (2006) 1.05
Human-murine transthyretin heterotetramers are kinetically stable and non-amyloidogenic. A lesson in the generation of transgenic models of diseases involving oligomeric proteins. J Biol Chem (2007) 1.04
In vivo seeding and cross-seeding of localized amyloidosis: a molecular link between type 2 diabetes and Alzheimer disease. Am J Pathol (2015) 1.03
Amyloid fibril formation by pulmonary surfactant protein C. FEBS Lett (1999) 1.02
BRICHOS - a superfamily of multidomain proteins with diverse functions. BMC Res Notes (2009) 1.02
Beta-amyloid protein converting enzyme 1 and brain-specific type II membrane protein BRI3: binding partners processed by furin. J Neurochem (2005) 1.02
Inherited surfactant protein-B deficiency and surfactant protein-C associated disease: clinical features and evaluation. Semin Perinatol (2006) 0.99
Pulmonary surfactant-associated polypeptide SP-C in lipid micelles: CD studies of intact SP-C and NMR secondary structure determination of depalmitoyl-SP-C(1-17). FEBS Lett (1995) 0.98
Kinetics of inhibition of beta-amyloid aggregation by transthyretin. Biochemistry (2006) 0.98
Transthyretin protects against A-beta peptide toxicity by proteolytic cleavage of the peptide: a mechanism sensitive to the Kunitz protease inhibitor. PLoS One (2008) 0.97
BRICHOS domains efficiently delay fibrillation of amyloid β-peptide. J Biol Chem (2012) 0.97
The Brichos domain-containing C-terminal part of pro-surfactant protein C binds to an unfolded poly-val transmembrane segment. J Biol Chem (2006) 0.97
Familial British dementia with amyloid angiopathy: early clinical, neuropsychological and imaging findings. Brain (2000) 0.96
Characterization of the interaction of β-amyloid with transthyretin monomers and tetramers. Biochemistry (2010) 0.95
Transthyretin inhibition of amyloid beta aggregation and toxicity. Clin Biochem (2005) 0.92
Identification of beta-amyloid-binding sites on transthyretin. Protein Eng Des Sel (2012) 0.91
Mechanisms of transthyretin inhibition of β-amyloid aggregation in vitro. J Neurosci (2013) 0.91
A synthetic surfactant based on a poly-Leu SP-C analog and phospholipids: effects on tidal volumes and lung gas volumes in ventilated immature newborn rabbits. J Appl Physiol (1985) (2003) 0.91
Amyloidogenic and anti-amyloidogenic properties of recombinant transthyretin variants. Amyloid (2004) 0.91
Systemic gene delivery to the central nervous system using Adeno-associated virus. Front Mol Neurosci (2014) 0.89
Serum transthyretin monomer in patients with familial amyloid polyneuropathy. Amyloid (2001) 0.88
Transthyretin suppresses the toxicity of oligomers formed by misfolded proteins in vitro. Biochim Biophys Acta (2013) 0.88
Localized structural fluctuations promote amyloidogenic conformations in transthyretin. J Mol Biol (2013) 0.88
The BRICHOS domain, amyloid fibril formation, and their relationship. Biochemistry (2013) 0.88
Effect of the disulfide bridge and the C-terminal extension on the oligomerization of the amyloid peptide ABri implicated in familial British dementia. Biochemistry (2001) 0.87
The systemic amyloid precursor transthyretin (TTR) behaves as a neuronal stress protein regulated by HSF1 in SH-SY5Y human neuroblastoma cells and APP23 Alzheimer's disease model mice. J Neurosci (2014) 0.87
Conformational preferences of non-polar amino acid residues: an additional factor in amyloid formation. Biochem Biophys Res Commun (2010) 0.87
Modifications of transthyretin in amyloid fibrils: analysis of amyloid from homozygous and heterozygous individuals with the Met30 mutation. EMBO J (1993) 0.86
Normal cognition in transgenic BRI2-Aβ mice. Mol Neurodegener (2013) 0.86
Properties of neurotoxic peptides related to the Bri gene. Protein Pept Lett (2004) 0.85
Assignment of the prealbumin (PALB) gene (familial amyloidotic polyneuropathy) to human chromosome region 18q11.2-q12.1. Hum Genet (1987) 0.84
A pulse-chase study tracking the conversion of macrophage-endocytosed serum amyloid A into extracellular amyloid. Arthritis Rheum (2002) 0.84
Immunization of Alzheimer model mice with adenovirus vectors encoding amyloid beta-protein and GM-CSF reduces amyloid load in the brain. Neurosci Lett (2004) 0.84
Kinetic analysis reveals the diversity of microscopic mechanisms through which molecular chaperones suppress amyloid formation. Nat Commun (2016) 0.84
First clinical data of the neuroprotective effects of nasal insulin application in patients with Alzheimer's disease. Alzheimers Dement (2014) 0.83
Structural basis of negative cooperativity in transthyretin. Acta Biochim Pol (2001) 0.82
Three-dimensional structure of the transthyretin-retinol-binding protein complex. Clin Chem Lab Med (2002) 0.82
Differential modification of Cys10 alters transthyretin's effect on beta-amyloid aggregation and toxicity. Protein Eng Des Sel (2009) 0.82
Structural requirements for intracellular targeting of SP-C proprotein. Am J Physiol (1999) 0.81